Correlation Between 17252MAP5 and Alvotech
Specify exactly 2 symbols:
By analyzing existing cross correlation between CTAS 345 01 MAY 25 and Alvotech, you can compare the effects of market volatilities on 17252MAP5 and Alvotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 17252MAP5 with a short position of Alvotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of 17252MAP5 and Alvotech.
Diversification Opportunities for 17252MAP5 and Alvotech
Modest diversification
The 3 months correlation between 17252MAP5 and Alvotech is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding CTAS 345 01 MAY 25 and Alvotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alvotech and 17252MAP5 is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CTAS 345 01 MAY 25 are associated (or correlated) with Alvotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alvotech has no effect on the direction of 17252MAP5 i.e., 17252MAP5 and Alvotech go up and down completely randomly.
Pair Corralation between 17252MAP5 and Alvotech
Assuming the 90 days trading horizon CTAS 345 01 MAY 25 is expected to under-perform the Alvotech. But the bond apears to be less risky and, when comparing its historical volatility, CTAS 345 01 MAY 25 is 7.73 times less risky than Alvotech. The bond trades about -0.05 of its potential returns per unit of risk. The Alvotech is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 1,135 in Alvotech on September 2, 2024 and sell it today you would earn a total of 40.00 from holding Alvotech or generate 3.52% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 76.56% |
Values | Daily Returns |
CTAS 345 01 MAY 25 vs. Alvotech
Performance |
Timeline |
CTAS 345 01 |
Alvotech |
17252MAP5 and Alvotech Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with 17252MAP5 and Alvotech
The main advantage of trading using opposite 17252MAP5 and Alvotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 17252MAP5 position performs unexpectedly, Alvotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alvotech will offset losses from the drop in Alvotech's long position.17252MAP5 vs. Alvotech | 17252MAP5 vs. Avadel Pharmaceuticals PLC | 17252MAP5 vs. Artisan Partners Asset | 17252MAP5 vs. Teleflex Incorporated |
Alvotech vs. Intracellular Th | Alvotech vs. Catalent | Alvotech vs. Amphastar P | Alvotech vs. Assertio Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |